Sentiment Summary
Recent Events
Alteogen is scheduled to present research results on the subcutaneous formulation of Antibody-Drug Conjugates (ADCs) using its ALT-B4 technology at the 'World ADC Asia 2026' forum, scheduled for June 9-11. Low market impact is expected as it is a research presentation, scheduled.
Final dividend of 0.75 yuan per share for fiscal year 2025 with an ex-dividend date of May 12, 2026 (Medium importance as dividend payouts typically support stock price) scheduled.
SK Hynix is scheduled to announce its Q1 2026 earnings results on April 29, 2026. Low importance is assigned as the market anticipates the upcoming data, scheduled.
Q1 2026 earnings release is scheduled.
Annual General Meeting for FY2025 and class shareholder meetings for A and H shares scheduled for April 21, 2026, to approve the profit distribution plan and amend the Articles of Association; neutral impact expected as these are routine administrative meetings scheduled
Ex-dividend date on April 10, 2026, for a final cash dividend of RMB 21.78 per 10 shares for the year ended December 31, 2025, with payment on May 14, 2026 scheduled
An online briefing for the 2025 annual results for investors on April 7, 2026, scheduled.
An online performance and cash dividend briefing for the 2025 annual results is scheduled to be held on April 7, 2026. Low impact estimated as it is a routine briefing scheduled
Samsung Fire & Marine Insurance Co Ltd announced on 2026-03-20, by board resolution rather than AGM approval, that it would cancel 1,363,682 common treasury shares and 92,490 preferred treasury shares, reducing outstanding shares for existing holders.
The 18th Annual General Meeting of Shareholders was held on March 31, 2026. Key agenda items included the approval of FY2025 financial statements, the appointment of directors, the establishment of an audit committee, and the transfer of 80 billion KRW from capital surplus to retained earnings for future shareholder returns.
The 12th Annual General Shareholders' Meeting is scheduled for 2026-03-31. Agenda items include approval of 2025 financial statements, the year-end dividend, and adding 'medical device business' to the articles of incorporation. Market impact is estimated at ~1% as these are standard agenda items scheduled.
On March 30, 2026, the company canceled 3,883,651 treasury shares (5.6% of total shares) following a board resolution on February 27, 2026.
The company's chairman announced a plan to acquire 3 billion KRW of company stock on April 27, 2026; market analysis estimates a High impact (>10%) due to strong signaling, scheduled.
Ex-dividend date on 2026-03-30 for a final dividend of KRW 5,800 per share for the fiscal year 2025 (approved at the AGM on 2026-03-26); high importance is expected due to the significant dividend yield, scheduled.
Ex-dividend date for the fiscal year 2025 cash dividend of KRW 1,500 per common share on 2026-03-30. The record date is 2026-03-31, with payment scheduled for late April 2026. Dividend yield is estimated at ~5%, likely causing a medium market reaction scheduled.
Announced on March 30, 2026, the partial early return of RMB 70 million in idle funds previously designated for supplementing working capital. This is a routine financial update.
Fiscal year 2025 results announcement on March 27, 2026, with revenue rising 35% to 9.18 billion yuan and attributable profit increasing to 1.10 billion yuan (High importance due to projected 35% revenue growth) expected.
Great Wall Motor announced its 2025 annual results on March 27, 2026, reporting a record revenue of CNY 222.82 billion (+10.2% YoY) but a 22.07% decline in net profit to CNY 9.87 billion. A price impact of ≥10% is estimated due to the significant profit drop, expected.
Announcement on March 27, 2026, of the July 13, 2026, global release for 'Ascend to ZERO'; low impact expected from new title schedule scheduled.
The ex-dividend date for the FY2025 cash dividend of KRW 7,600 per common share on March 26, 2026, following approval at the AGM on March 20, 2026.
Announced full-year 2025 financial results on March 26, 2026. Revenue increased by 30.0% YoY to RMB 5.05 billion, and net profit rose by 36.8% YoY to RMB 1.205 billion. The results exceeded market expectations, and the stock price surged nearly 13% in early trading the following day.
Full-year 2025 earnings released: Revenue fell 10.95% to CNY 126.01B, while net profit rose 1.39% to CNY 6.07B, aided by lower coal costs. The stock price declined over 5% in the following days, reacting to the revenue drop and a lower power generation forecast for 2026.
Announcement of a KRW 44.28 billion supply contract for Cenobamate (Xcopri) with U.S. subsidiary SK Life Science, Inc. on March 26, 2026, scheduled. This is an internal transfer for U.S. sales with a neutral market impact expected.
Multiple analysts forecast strong 2026 net profit growth of 26% YoY to RMB 91.0 billion; medium impact expected from positive growth outlook forecasted
Bank of America analysts lowered the target price for the H-shares to HKD 5.0 from HKD 5.5 on 2026-03-26, citing concerns over falling electricity prices and rising fuel costs. The target price cut is estimated to result in a medium price impact (≥5%), forecasted.
25th Annual General Meeting on 2026-03-26 to approve dividend payment and appointment of new outside director Chae Eun-mi; low importance is expected as it is a routine administrative meeting, scheduled.
Announced a rapid expansion in Europe on March 26, 2026, launching its brand and vehicles in Spain, Germany, the Netherlands, Belgium, and Luxembourg.
Annual dividend ex-date for FY2025 (KRW 19,500 per common share) on March 25, 2026. The record date was March 27, 2026.
Ex-dividend date (2026-03-25) for the annual dividend of KRW 2,800 per share for the fiscal year 2025, approved at the AGM on 2026-03-19. High importance reflects an estimated price impact exceeding 10%.
Alteogen signed an exclusive license agreement with Biogen to develop and commercialize two subcutaneous (SC) products using Alteogen's ALT-B4 platform. The deal is worth up to $579 million, including a $20 million upfront payment, plus future royalties.
Full-year 2025 results announced on March 25, 2026, reporting a 13.3% revenue increase to RMB 80.22 billion and a 13.9% profit increase with a recommended dividend of HKD 1.08; High importance reflects an estimated >10% price impact, expected
Announced a new 2026-2028 shareholder return policy and a plan to return approximately 310 billion KRW starting in 2026. This is a significant increase from the previous year's return program.
Decided to cancel 76.6 billion KRW worth of treasury stock (128,729 shares) on April 1, 2026, to enhance shareholder value. This is a corporate action that reduces the total number of shares outstanding.
Announced FY2025 results: Revenue of $3.42B (down 10.4% YoY), but profit attributable to owners rose 1.5% to $404M. A final dividend of 4.1446 US cents per share was proposed. The results were seen as positive, with the share price reportedly rising afterward.
Announced 2025 annual results with revenue up 13.02% YoY to RMB 31.63 billion and net profit up 21.69% YoY to RMB 7.71 billion. A final dividend of RMB 2.00 per 10 shares was proposed. Medium impact estimated due to significant profit growth scheduled
Approved the transfer of 5.89 trillion KRW from capital reserve to retained earnings to secure financial resources for future shareholder returns.
Announced a corporate value enhancement plan, targeting 20% average annual sales growth in core businesses by 2028, a 20% operating profit margin, and a dividend payout ratio of 50-70% for the next three years, including the introduction of quarterly dividends.
Launch of a new TV commercial and advertising campaign for the 'Booster Pro X2' beauty device featuring brand model Jang Won-young. Marketing events typically have a low immediate price impact of ~1% scheduled.
Secured an order for four 50,000 DWT Product Carrier (PC) ships from European firm Hayfin Capital Management, valued at approximately 300 billion KRW.
Filed for a court injunction to prevent the Defense Acquisition Program Administration (DAPA) from sharing its basic design data for the KDDX-class destroyer with competitor Hanwha Ocean.
Appointed Mr. Kim Jeong-gyu as the new CEO following the annual general meeting.